Ignite Creation Date:
2024-05-06 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06213818
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2024-01-10
Brief Title:
A Study to Evaluate the Safety Tolerability and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Study Overview
Official Title:
A Phase 1 Double-Blind Randomized Placebo-Controlled Single-Dose Dose-Escalation Drug-Interaction and Food-Effect Study to Assess the Safety Tolerability and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participants
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to assess the Safety Tolerability and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None